Home » Topics » BioWorld

BioWorld
RSS

APPLIED IMMUNE FILES FOR OFFERING

Jan. 10, 1992

DNX PIGS WITH MORE HUMAN HEMOGLOBIN

Jan. 10, 1992

MATRIX FILES FOR 2.5 MILLION-SHARE IPO

Jan. 10, 1992

CHIRON COMPLETES INTRAOPTICS ACQUISITION

Jan. 10, 1992

BIOMIRA STOCK CONTINUES TO RISE

Jan. 9, 1992

CALGENE TO GET ANTISENSE PATENT

Jan. 9, 1992

IMMUNOMEDICS TO GET BROAD PATENT

Jan. 9, 1992

GENSIA, SANDOZ TO PURSUE DIABETES DRUGS

Jan. 9, 1992

GENPHARM RAISES $12 MILLION

Jan. 9, 1992

COLLAGEN LAWSUIT DROPPED

Jan. 9, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...